Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
about
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy.Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy.Surface Probing by Fragment-Based Screening and Computational Methods Identifies Ligandable Pockets on the von Hippel-Lindau (VHL) E3 Ubiquitin LigaseSmall-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
P2860
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
@en
Chemically induced degradation of CDK9 by a proteolysis targeting chimera
@nl
type
label
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
@en
Chemically induced degradation of CDK9 by a proteolysis targeting chimera
@nl
prefLabel
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
@en
Chemically induced degradation of CDK9 by a proteolysis targeting chimera
@nl
P2093
P2860
P50
P356
P1476
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
@en
P2093
Caroline M Robb
Jacob I Contreras
Margaret A Taylor
Sandeep Rana
P2860
P304
P356
10.1039/C7CC03879H
P407
P577
2017-06-21T00:00:00Z